Literature DB >> 20801881

An exceptionally potent inducer of cytoprotective enzymes: elucidation of the structural features that determine inducer potency and reactivity with Keap1.

Albena T Dinkova-Kostova1, Paul Talalay, John Sharkey, Ying Zhang, W David Holtzclaw, Xiu Jun Wang, Emilie David, Katherine H Schiavoni, Stewart Finlayson, Dale F Mierke, Tadashi Honda.   

Abstract

The Keap1/Nrf2/ARE pathway controls a network of cytoprotective genes that defend against the damaging effects of oxidative and electrophilic stress, and inflammation. Induction of this pathway is a highly effective strategy in combating the risk of cancer and chronic degenerative diseases, including atherosclerosis and neurodegeneration. An acetylenic tricyclic bis(cyano enone) bearing two highly electrophilic Michael acceptors is an extremely potent inducer in cells and in vivo. We demonstrate spectroscopically that both cyano enone functions of the tricyclic molecule react with cysteine residues of Keap1 and activate transcription of cytoprotective genes. Novel monocyclic cyano enones, representing fragments of rings A and C of the tricyclic compound, reveal that the contribution to inducer potency of the ring C Michael acceptor is much greater than that of ring A, and that potency is further enhanced by spatial proximity of an acetylenic function. Critically, the simultaneous presence of two cyano enone functions in rings A and C within a rigid three-ring system results in exceptionally high inducer potency. Detailed understanding of the structural elements that contribute to the reactivity with the protein sensor Keap1 and to high potency of induction is essential for the development of specific and selective lead compounds as clinically relevant chemoprotective agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801881      PMCID: PMC2962473          DOI: 10.1074/jbc.M110.163485

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis.

Authors:  Paul Talalay; Albena T Dinkova-Kostova; W David Holtzclaw
Journal:  Adv Enzyme Regul       Date:  2003

Review 2.  The "Prochaska" microtiter plate bioassay for inducers of NQO1.

Authors:  Jed W Fahey; Albena T Dinkova-Kostova; Katherine K Stephenson; Paul Talalay
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

3.  Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver.

Authors:  V P Kelly; E M Ellis; M M Manson; S A Chanas; G J Moffat; R McLeod; D J Judah; G E Neal; J D Hayes
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

4.  A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production.

Authors:  Tadashi Honda; Yukiko Honda; Frank G Favaloro; Gordon W Gribble; Nanjoo Suh; Andrew E Place; Mara H Rendi; Michael B Sporn
Journal:  Bioorg Med Chem Lett       Date:  2002-04-08       Impact factor: 2.823

5.  Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates.

Authors:  Y Zhang
Journal:  Carcinogenesis       Date:  2001-03       Impact factor: 4.944

6.  Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups.

Authors:  A T Dinkova-Kostova; M A Massiah; R E Bozak; R J Hicks; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

7.  Glutathione S-transferases (rat and human).

Authors:  W H Habig; W B Jakoby
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

8.  Design and synthesis of tricyclic compounds with enone functionalities in rings A and C: a novel class of highly active inhibitors of nitric oxide production in mouse macrophages.

Authors:  Frank G Favaloro; Tadashi Honda; Yukiko Honda; Gordon W Gribble; Nanjoo Suh; Renee Risingsong; Michael B Sporn
Journal:  J Med Chem       Date:  2002-10-24       Impact factor: 7.446

9.  Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease.

Authors:  Cliona Stack; Daniel Ho; Elizabeth Wille; Noel Y Calingasan; Charlotte Williams; Karen Liby; Michael Sporn; Magali Dumont; M Flint Beal
Journal:  Free Radic Biol Med       Date:  2010-03-23       Impact factor: 7.376

10.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants.

Authors:  Albena T Dinkova-Kostova; W David Holtzclaw; Robert N Cole; Ken Itoh; Nobunao Wakabayashi; Yasutake Katoh; Masayuki Yamamoto; Paul Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

View more
  41 in total

1.  A generalizable platform for interrogating target- and signal-specific consequences of electrophilic modifications in redox-dependent cell signaling.

Authors:  Hong-Yu Lin; Joseph A Haegele; Michael T Disare; Qishan Lin; Yimon Aye
Journal:  J Am Chem Soc       Date:  2015-05-05       Impact factor: 15.419

2.  Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Rebecca Banerjee; Lichuan Yang; Natalya A Smirnova; Dmitry M Hushpulian; Karen T Liby; Charlotte R Williams; Masayuki Yamamoto; Thomas W Kensler; Rajiv R Ratan; Michael B Sporn; M Flint Beal; Irina G Gazaryan; Bobby Thomas
Journal:  Antioxid Redox Signal       Date:  2012-08-13       Impact factor: 8.401

3.  Activator protein-1 regulation of murine aldehyde dehydrogenase 1a1.

Authors:  N L Makia; I Amunom; K C Falkner; D J Conklin; S Surapureddi; J A Goldstein; R A Prough
Journal:  Mol Pharmacol       Date:  2012-06-26       Impact factor: 4.436

4.  HSF1-dependent upregulation of Hsp70 by sulfhydryl-reactive inducers of the KEAP1/NRF2/ARE pathway.

Authors:  Ying Zhang; Young-Hoon Ahn; Ivor J Benjamin; Tadashi Honda; Ronald J Hicks; Vittorio Calabrese; Philip A Cole; Albena T Dinkova-Kostova
Journal:  Chem Biol       Date:  2011-11-23

Review 5.  Role of nrf2 in oxidative stress and toxicity.

Authors:  Qiang Ma
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

6.  Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.

Authors:  Paul A Jackson; John C Widen; Daniel A Harki; Kay M Brummond
Journal:  J Med Chem       Date:  2016-12-20       Impact factor: 7.446

Review 7.  Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents.

Authors:  Sadagopan Magesh; Yu Chen; Longqin Hu
Journal:  Med Res Rev       Date:  2012-05-01       Impact factor: 12.944

Review 8.  Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2.

Authors:  Qiang Ma; Xiaoqing He
Journal:  Pharmacol Rev       Date:  2012-09-10       Impact factor: 25.468

9.  Relevance of anti-inflammatory and antioxidant activities of exemestane and synergism with sulforaphane for disease prevention.

Authors:  Hua Liu; Paul Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

Review 10.  Small molecule activators of the heat shock response: chemical properties, molecular targets, and therapeutic promise.

Authors:  James D West; Yanyu Wang; Kevin A Morano
Journal:  Chem Res Toxicol       Date:  2012-07-31       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.